Swedish Orphan Biovitrum
Biopharmaceutical company developing treatments for rare haematology and immunology diseases.
SOBI | ST
Overview
Corporate Details
- ISIN(s):
- SE0000872095 (+51 more)
- LEI:
- 549300124Y3MQI87PT35
- Country:
- Sweden
- Address:
- Tomtebodavagen 23A, 112 76 Stockholm
- Website:
- https://www.sobi.com/en
- Sector:
- Manufacturing
Description
Swedish Orphan Biovitrum (Sobi) is a specialized biopharmaceutical company dedicated to developing and delivering innovative treatments for rare and debilitating diseases. The company's primary focus is on the therapeutic areas of haematology and immunology, with a significant legacy and continued leadership in haemophilia care. Sobi addresses the high unmet medical needs of patients by advancing a pipeline of innovative medicines and working to expand patient access globally. The company's mission is to transform the lives of people affected by rare conditions through dedicated research, development, and global collaboration.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-13 17:00 |
Sobi förvärvar Arthrosi Therapeutics och stärker sin pipeline med potentiell be…
|
Swedish | 83.0 KB | ||
| 2025-12-13 17:00 |
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential…
|
English | 136.9 KB | ||
| 2025-10-21 13:00 |
Förändring i Sobis styrelse
|
Swedish | 132.4 KB | ||
| 2025-10-21 13:00 |
Change in the Sobi Board of Directors
|
English | 98.8 KB | ||
| 2025-10-20 08:00 | Swedish | 3.8 MB | |||
| 2025-10-20 08:00 | English | 4.1 MB | |||
| 2025-10-19 20:30 |
Sobi meddelar reviderade helårsutsikter och tidigarelägger publiceringen av del…
|
Swedish | 206.4 KB | ||
| 2025-10-19 20:30 |
Sobi announces revised full year outlook and advances publication of the Q3 202…
|
English | 174.2 KB | ||
| 2025-09-30 08:00 |
New number of shares and votes in Sobi
|
English | 137.5 KB | ||
| 2025-09-30 08:00 |
Ändring av antalet aktier och röster i Sobi
|
Swedish | 126.9 KB | ||
| 2025-08-29 08:00 |
Ändring av antalet aktier och röster i Sobi
|
Swedish | 100.2 KB | ||
| 2025-08-29 08:00 |
New number of shares and votes in Sobi
|
English | 97.9 KB | ||
| 2025-08-21 12:35 |
Sobi has completed issues of class C shares
|
English | 151.8 KB | ||
| 2025-08-21 12:35 |
Sobi har genomfört emissioner av C-aktier
|
Swedish | 151.6 KB | ||
| 2025-07-16 08:00 | Swedish | 4.1 MB |
Automate Your Workflow. Get a real-time feed of all Swedish Orphan Biovitrum filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Swedish Orphan Biovitrum
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Swedish Orphan Biovitrum via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | Katy Mazibuko | Other | Sell | 1,500 | 480,000.00 SEK |
| 2024-08-30 | Katy Mazibuko | Other | Sell | 269 | 86,012.75 SEK |
| 2024-08-12 | Sara Karlsson | Other | Buy | 86 | 23,391.79 SEK |
| 2024-07-25 | Mahmood Ladha | Other | Buy | 84,585 | 12,360,406.05 SEK |
| 2024-07-23 | Mahmood Ladha | Other | Sell | 84,585 | 24,614,235.00 SEK |
| 2024-06-10 | Christin Wesström | Other | Other | 7,433 | N/A |
| 2024-06-03 | Guido Oelkers | Other | Buy | 117,332 | 23,965,061.00 SEK |
| 2024-05-30 | Guido Oelkers | Other | Sell | 117,332 | 32,090,302.00 SEK |
| 2024-05-15 | Henrik Stenqvist | Other | Buy | 72,534 | 14,815,069.50 SEK |
| 2024-05-13 | Henrik Stenqvist | Other | Sell | 72,534 | 20,766,484.20 SEK |
Peer Companies
